Literature DB >> 23856820

Testicular function and bone metabolism--beyond testosterone.

Alberto Ferlin1, Riccardo Selice, Umberto Carraro, Carlo Foresta.   

Abstract

Findings in the past few years have advanced understanding of the crosstalk between testis and bone and could contribute to defining an improved clinical approach to the biochemical diagnosis and therapeutic management of hypogonadism and male osteoporosis. This Review focuses on the Leydig cells of the testis. Other than being responsible for steroidogenesis and production of testosterone, the function of these cells is fundamental to bone health in at least two other ways: Leydig cells produce insulin-like 3 (INSL3), which has a role in osteoblast function, and they contribute to 25-hydroxylation of vitamin D. Impairment of testicular function leads to low levels of testosterone, INSL3 and 25-hydroxyvitamin D and consequently to an increased risk of osteopenia and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23856820     DOI: 10.1038/nrendo.2013.135

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  67 in total

1.  Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

Authors:  S Khosla; L J Melton; E J Atkinson; W M O'Fallon
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

Review 2.  Subclinical male hypogonadism.

Authors:  Elisa Giannetta; Daniele Gianfrilli; Federica Barbagallo; Andrea M Isidori; Andrea Lenzi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-05-22       Impact factor: 4.690

3.  Cryptorchidism in mice mutant for Insl3.

Authors:  S Nef; L F Parada
Journal:  Nat Genet       Date:  1999-07       Impact factor: 38.330

4.  T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane.

Authors:  Natalia V Bogatcheva; Alberto Ferlin; Shu Feng; Anne Truong; Lisa Gianesello; Carlo Foresta; Alexander I Agoulnik
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-08-22       Impact factor: 4.310

Review 5.  Membrane receptors: structure and function of the relaxin family peptide receptors.

Authors:  Roy C K Kong; Patrick J Shilling; Derek K Lobb; Paul R Gooley; Ross A D Bathgate
Journal:  Mol Cell Endocrinol       Date:  2010-02-06       Impact factor: 4.102

6.  Association of vitamin D status with serum androgen levels in men.

Authors:  E Wehr; S Pilz; B O Boehm; W März; B Obermayer-Pietsch
Journal:  Clin Endocrinol (Oxf)       Date:  2009-12-29       Impact factor: 3.478

7.  Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts.

Authors:  Takashi Nakamura; Yuuki Imai; Takahiro Matsumoto; Shingo Sato; Kazusane Takeuchi; Katsuhide Igarashi; Yoshifumi Harada; Yoshiaki Azuma; Andree Krust; Yoko Yamamoto; Hiroshi Nishina; Shu Takeda; Hiroshi Takayanagi; Daniel Metzger; Jun Kanno; Kunio Takaoka; T John Martin; Pierre Chambon; Shigeaki Kato
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

8.  Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells.

Authors:  I M Adham; E Burkhardt; M Benahmed; W Engel
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

9.  Genetic alterations associated with cryptorchidism.

Authors:  Alberto Ferlin; Daniela Zuccarello; Biagio Zuccarello; Maria Rosaria Chirico; Giovanni Franco Zanon; Carlo Foresta
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

Review 10.  Sex hormones, their receptors and bone health.

Authors:  K Venken; F Callewaert; S Boonen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2008-04-05       Impact factor: 4.507

View more
  27 in total

Review 1.  Relaxin and insulin-like peptide 3 in the musculoskeletal system: from bench to bedside.

Authors:  Alberto Ferlin; Luca De Toni; Marco Sandri; Carlo Foresta
Journal:  Br J Pharmacol       Date:  2016-05-05       Impact factor: 8.739

2.  Estrogens, the be-all and end-all of male hypogonadal bone loss?

Authors:  M R Laurent; E Gielen; D Vanderschueren
Journal:  Osteoporos Int       Date:  2014-11-07       Impact factor: 4.507

Review 3.  Impact of thyroid disease on testicular function.

Authors:  Sandro La Vignera; Roberto Vita; Rosita A Condorelli; Laura M Mongioì; Silvia Presti; Salvatore Benvenga; Aldo E Calogero
Journal:  Endocrine       Date:  2017-04-20       Impact factor: 3.633

4.  The association of testosterone, sex hormone-binding globulin, and insulin-like growth factor-1 with bone parameters in Korean men aged 50 years or older.

Authors:  Hye-Jung Kim; Hyung Suk Koo; Young-Sang Kim; Moon Jong Kim; Kwang-Min Kim; Nam-Seok Joo; Ji-Hee Haam
Journal:  J Bone Miner Metab       Date:  2016-11-21       Impact factor: 2.626

5.  Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.

Authors:  A Ferlin; R Selice; A Di Mambro; M Ghezzi; A Di Nisio; N Caretta; C Foresta
Journal:  Osteoporos Int       Date:  2015-05-12       Impact factor: 4.507

Review 6.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

7.  Steroidogenic fate of the Leydig cells that repopulate the testes of young and aged Brown Norway rats after elimination of the preexisting Leydig cells.

Authors:  Haolin Chen; Jingjing Guo; Renshan Ge; Qingquan Lian; Vassilios Papadopoulos; Barry R Zirkin
Journal:  Exp Gerontol       Date:  2015-09-01       Impact factor: 4.032

Review 8.  Role of non-receptor protein tyrosine kinases in spermatid transport during spermatogenesis.

Authors:  H T Wan; Dolores D Mruk; Elizabeth I Tang; Xiang Xiao; Yan-Ho Cheng; Elissa W P Wong; Chris K C Wong; C Yan Cheng
Journal:  Semin Cell Dev Biol       Date:  2014-04-12       Impact factor: 7.727

9.  Chemokine-like receptor 1 deficiency leads to lower bone mass in male mice.

Authors:  Huashan Zhao; Dewen Yan; Liang Xiang; Chen Huang; Jian Li; Xiangfang Yu; Binbin Huang; Baobei Wang; Jie Chen; Tianxia Xiao; Pei-Gen Ren; Jian V Zhang
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

Review 10.  Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds.

Authors:  Hooi Hooi Ng; Maria Esteban-Lopez; Alexander I Agoulnik
Journal:  Mol Cell Endocrinol       Date:  2018-12-24       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.